Alpha 1-antitrypsin deficiency differential diagnosis: Difference between revisions
Mazia Fatima (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Alpha 1-antitrypsin deficiency has to be differentiated from other conditions with similar presentation like autoimmune hepatitis, bronchiectasis, bronchitis, chronic obstructive pulmonary disease (COPD),cystic fibrosis,emphysema,primary ciliary dyskinesia (Kartagener Syndrome),viral hepatitis. | Alpha 1-antitrypsin deficiency has to be differentiated from other conditions with similar presentation like [[autoimmune hepatitis]], [[bronchiectasis]], [[bronchitis]], [[Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease (COPD)]],[[cystic fibrosis]],[[emphysema]],[[primary ciliary dyskinesia]] ([[Kartagener's Syndrome|Kartagener Syndrome]]),[[viral hepatitis]]. | ||
==Differentiating Alpha 1-antitrypsin deficiency from Other Diseases== | ==Differentiating Alpha 1-antitrypsin deficiency from Other Diseases== | ||
Alpha 1-antitrypsin deficiency presents with symptoms of | Alpha 1-antitrypsin deficiency presents with symptoms of [[emphysema]] associated with compromised [[Liver function tests abnormality|liver function tests]] and/or [[cirrhosis]]. Differential diagnosis of includes: | ||
Differential diagnosis of | |||
'''Jaundice and RUQ pain differential diagnosis are:''' | '''Jaundice and RUQ pain differential diagnosis are:''' | ||
Line 39: | Line 37: | ||
|- | |- | ||
! rowspan="12" style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice | ! rowspan="12" style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice | ||
! colspan="1" rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Hepatocellular Jaundice | ! colspan="1" rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Hepatocellular Disease|Hepatocellular Jaundice]] | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hemochromatosis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemochromatosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 52: | Line 50: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Ferritin ↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ferritin]] ↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Liver biopsy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Liver biopsy]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Wilson's disease | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Wilson's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 67: | Line 65: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Serum cerulloplasmin ↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ceruloplasmin|Serum cerulloplasmin]] ↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Liver biopsy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Liver biopsy]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Alcoholic hepatitis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Alcoholic hepatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
Line 85: | Line 83: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cirrhosis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
Line 97: | Line 95: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑/N | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑/N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombocytopenia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Liver|hypotrophied liver on ultrasound]] | ||
|- | |- | ||
!Alpha 1-antitrypsin deficiency | ![[Alpha 1-antitrypsin deficiency]] | ||
!+ | !+ | ||
!-/+ | !-/+ | ||
Line 112: | Line 110: | ||
!↑/N | !↑/N | ||
!- | !- | ||
!Serum alpha1-antitrypsin levels decreased | ![[Alpha1 antitrypsin|Serum alpha1-antitrypsin levels]] decreased | ||
!Hepatomegaly on CT | ![[Hepatomegaly]] on [[CT-scans|CT]] | ||
|- | |- | ||
! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Cholestatic Jaundice | ! rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Cholestatic]] [[Jaundice]] | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Common bile duct stone | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Bile duct|Common bile duct stone]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 128: | Line 126: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Dilated ducts on | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Dilated ducts on [[sonography]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT/ERCP | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CT]]/[[ERCP]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hepatitis A cholestatic type | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis A]] [[Cholestatic|cholestatic type]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
Line 143: | Line 141: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |HAV- AB | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HAV infection|HAV- AB]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abdominal ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ultrasound|Abdominal ultrasound]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |EBV / CMV hepatitis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Epstein Barr virus|EBV]] / [[CMV infection|CMV]] [[hepatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
Line 158: | Line 156: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Positive serology | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Serology|Positive serology]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Primary biliary cirrhosis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary biliary cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 173: | Line 171: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |AMA positive | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-mitochondrial antibody|AMA positive]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Liver biopsy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Liver biopsy]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Primary sclerosing cholangitis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 188: | Line 186: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Beading on MRCP | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Beading on [[Magnetic resonance cholangiopancreatography|MRCP]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Liver biopsy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Liver biopsy]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pancreatic carcinoma | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pancreatic carcinoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 203: | Line 201: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mass on | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mass on [[ultrasound]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT scan for diagnosis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CT scanning|CT scan]] for [[diagnosis]] | ||
|- | |- | ||
|} | |} | ||
Line 516: | Line 514: | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Alpha-1 antitrypsin deficiency | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Alpha-1 antitrypsin deficiency | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|N | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|Genetic testing | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Genetic testing | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|Liver biopsy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Liver biopsy | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Breast feeding failure jaundice | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Breast feeding failure jaundice | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Breast Milk Jaundice | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Breast Milk Jaundice | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|↑ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"|<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki> | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Crigler-Najjar type 2 | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Crigler-Najjar type 2 |
Revision as of 21:09, 5 January 2018
Alpha 1-antitrypsin deficiency Microchapters |
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Alpha 1-antitrypsin deficiency differential diagnosis On the Web |
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency differential diagnosis |
FDA on Alpha 1-antitrypsin deficiency differential diagnosis |
CDC on Alpha 1-antitrypsin deficiency differential diagnosis |
Alpha 1-antitrypsin deficiency differential diagnosis in the news |
Blogs on Alpha 1-antitrypsin deficiency differential diagnosis |
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overview
Alpha 1-antitrypsin deficiency has to be differentiated from other conditions with similar presentation like autoimmune hepatitis, bronchiectasis, bronchitis, chronic obstructive pulmonary disease (COPD),cystic fibrosis,emphysema,primary ciliary dyskinesia (Kartagener Syndrome),viral hepatitis.
Differentiating Alpha 1-antitrypsin deficiency from Other Diseases
Alpha 1-antitrypsin deficiency presents with symptoms of emphysema associated with compromised liver function tests and/or cirrhosis. Differential diagnosis of includes:
Jaundice and RUQ pain differential diagnosis are:
|
The differential diagnosis of jaundice, fever, and RUQ pain are:
|
Diseases | Symptoms | Signs | Diagosis | |||||
---|---|---|---|---|---|---|---|---|
Fever | Cough | Chest pain | Wheezes | Crackles | Tachypnea | Lab tests | Imaging | |
Asthma | - | Dry/Productive | - | + | - | + |
|
|
Bronchiolitis | +/- | Dry | - | + | + | +/- |
|
|
COPD | + | Productive | - | + | + | + |
|
|
Bacterial pneumonia | + | Productive | + | + | + | +/- |
|
|
Cystic Fibrosis | +/- | Productive | +/- | - | - | + | Cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction evidenced by :
|
Xray :
Hyperinflation presents as:
Abdominal findings include dilated multiple loops of the small bowel are seen in neonatal meconium ileus and in meconium ileus. |
Emphysema | +/- | Productive | - | + | +/- | + |
|
Chest X-ray reveals signs of emphysema include:
|
Primary Ciliary Dyskinesia (Kartagener Syndrome) | +/- | Productive | - | + | + | + | Low or absent amount of nasal nitric oxide (nNO). mucociliary clearance may be useful for screening,
confirmation with tests of ciliary function and ultrastructure |
Chest X-ray reveals :
Bronchial wall thickening Bronchiectasis and hyperinflation Cystic bronchiectasis with air-fluid levels may be visible Usually involves the lower and middle lobes. |
Alpha 1-antitrypsin deficiency | +/- | Productive | - | + | + | + | Reduced concentration of serum alpha1-antitrypsin levels is diagnostic of AATD.
Moderate-to-severe airflow obstruction with an FEV1 Reduced vital capacity Increased lung volumes secondary to air trapping (residual volume >120% of predicted value) are usually present |
Chest Xray Alpha1-antitrypsin deficiency (AATD) emphysema presents as:
|
AATD can present as neonatal jaundice. The diffrential diagnosis for neonatal jaundice is: [3]
|
References
- ↑ Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HM; et al. (2008). "An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients". Respir Med. 102 (6): 825–30. doi:10.1016/j.rmed.2008.01.016. PMID 18339530.
- ↑ Lazović B, Svenda MZ, Mazić S, Stajić Z, Delić M (2013). "Analysis of electrocardiogram in chronic obstructive pulmonary disease patients". Med Pregl. 66 (3–4): 126–9. PMID 23653989.
- ↑ Fargo MV, Grogan SP, Saguil A (2017). "Evaluation of Jaundice in Adults". Am Fam Physician. 95 (3): 164–168. PMID 28145671.